INTS vs VLTO · $7.7M cap vs P/E 29, rev $5.19B
Intensity Therapeutics, Inc. Common stock (INTS) versus Veralto Corporation (VLTO) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Veralto Corporation (VLTO) is a pollution & treatment controls company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported VLTO revenue for 2024-12-31 was $5.19B. Net income was $833.0M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
INTS currently screens at market cap $7.7M. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
Not investment advice. Open the INTS and VLTO stock pages for the full models.
Not investment advice.